LYKA LABS
Back to Cashflow Statement
|
LYKA LABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹5.29 Cr | ₹1.95 Cr | ₹-22 Cr | ₹-63 Cr | ₹-12 Cr |
What is the latest Cash Flow from Financing Activities ratio of LYKA LABS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹5.29 Cr |
| Mar2024 | ₹1.95 Cr |
| Mar2023 | ₹-22 Cr |
| Mar2022 | ₹-63 Cr |
| Mar2021 | ₹-12 Cr |
How is Cash Flow from Financing Activities of LYKA LABS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.29 Cr | 170.97 | |
| Mar2024 | ₹1.95 Cr | Positive | |
| Mar2023 | ₹-22 Cr | Negative | |
| Mar2022 | ₹-63 Cr | Negative | |
| Mar2021 | ₹-12 Cr | - | |
Compare Cash Flow from Financing Activities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹255.3 Cr | -0.7% | -11.8% | -51.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,439.0 Cr | 5.7% | -3.3% | -2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,903.0 Cr | 1.6% | -7.6% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,466.0 Cr | -0.5% | 0.9% | 23.6% | Stock Analytics | |
| CIPLA | ₹107,653.0 Cr | 0.5% | -12.9% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,924.0 Cr | 5.3% | -0.9% | 1.9% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -0.7% |
-11.8% |
-51.9% |
| SENSEX | 1.3% |
-2.5% |
8.5% |
You may also like the below Video Courses